Compare BNTC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTC | CGC |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.4M | 404.3M |
| IPO Year | 2020 | 2023 |
| Metric | BNTC | CGC |
|---|---|---|
| Price | $13.25 | $1.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | 95.9K | ★ 7.9M |
| Earning Date | 05-13-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.94 | 36.75 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $11.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $0.84 |
| 52 Week High | $17.15 | $2.38 |
| Indicator | BNTC | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 71.97 | 57.82 |
| Support Level | $12.79 | $1.01 |
| Resistance Level | $14.13 | $1.10 |
| Average True Range (ATR) | 0.65 | 0.07 |
| MACD | 0.24 | 0.02 |
| Stochastic Oscillator | 99.86 | 88.03 |
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.